Bedaquiline Fumarate
- Generic Name
- Bedaquiline Fumarate
TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
Phase 2
Completed
- Conditions
- Tuberculosis
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2012-08-15
- Lead Sponsor
- Tibotec BVBA
- Target Recruit Count
- 75
- Registration Number
- NCT00523926
TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
Phase 2
Completed
- Conditions
- Tuberculosis
- Interventions
- Drug: PlaceboDrug: Background regimen (BR) for MDR-TB (multi-drug resistant tuberculosis)
- First Posted Date
- 2007-03-20
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- Janssen Infectious Diseases BVBA
- Target Recruit Count
- 208
- Registration Number
- NCT00449644
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath